Myosin Light Chain 9/12 Regulates the Pathogenesis of Inflammatory Bowel Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Myosin Light Chain 9/12 Regulates the Pathogenesis of Inflammatory Bowel Disease
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-29
DOI
10.3389/fimmu.2020.594297
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new therapeutic target: the CD69-Myl9 system in immune responses
- (2019) Motoko Y. Kimura et al. Seminars in Immunopathology
- Effector T Helper Cell Subsets in Inflammatory Bowel Diseases
- (2018) Tanbeena Imam et al. Frontiers in Immunology
- Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches
- (2017) R. Balfour Sartor et al. GASTROENTEROLOGY
- Crucial role for CD69 in allergic inflammatory responses: CD69-Myl9 system in the pathogenesis of airway inflammation
- (2017) Motoko Y. Kimura et al. IMMUNOLOGICAL REVIEWS
- Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease
- (2017) Guang Xi Zhou et al. Journal of Digestive Diseases
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
- (2017) Siew C Ng et al. LANCET
- Ulcerative colitis
- (2017) Ryan Ungaro et al. LANCET
- Environmental risk factors for inflammatory bowel diseases: Evidence based literature review
- (2016) Ayokunle T Abegunde et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Impact of New Treatments on Hospitalisation, Surgery, Infection, and Mortality in IBD: a Focus Paper by the Epidemiology Committee of ECCO
- (2015) Vito Annese et al. Journal of Crohns & Colitis
- Regulatory immune cells in regulation of intestinal inflammatory response to microbiota
- (2015) M Sun et al. Mucosal Immunology
- Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy
- (2014) Raquel Franco Leal et al. GUT
- Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome
- (2013) Dan Knights et al. GUT
- Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011
- (2013) Christine Rungoe et al. GUT
- Crucial Role for CD69 in the Pathogenesis of Dextran Sulphate Sodium-Induced Colitis
- (2013) Akihiro Hasegawa et al. PLoS One
- The Early Activation Marker CD69 Regulates the Expression of Chemokines and CD4 T Cell Accumulation in Intestine
- (2013) Katarina Radulovic et al. PLoS One
- Long-term Outcome of Patients With Crohn's Disease Who Respond to Azathioprine
- (2012) Marine Camus et al. Clinical Gastroenterology and Hepatology
- Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?
- (2012) Ashwin D. Dhanda et al. INFLAMMATORY BOWEL DISEASES
- CD69 Regulates Type I IFN-Induced Tolerogenic Signals to Mucosal CD4 T Cells That Attenuate Their Colitogenic Potential
- (2012) K. Radulovic et al. JOURNAL OF IMMUNOLOGY
- Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease
- (2010) Mario Cottone et al. Clinical Gastroenterology and Hepatology
- CD69 Controls the Pathogenesis of Allergic Airway Inflammation
- (2009) T. Miki-Hosokawa et al. JOURNAL OF IMMUNOLOGY
- Infliximab for Inflammatory Bowel Disease in Denmark 1999–2005: Clinical Outcome and Follow-Up Evaluation of Malignancy and Mortality
- (2008) Sarah Caspersen et al. Clinical Gastroenterology and Hepatology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started